Butapar MR Tablet
By Butapar MR
Rx
10 Tablet in a Strip

Composition
Chlorzoxazone(250mg) + Diclofenac(50mg) + Paracetamol(325mg)

Manufacturer - Oyster Labs Ltd
81, Industrial Estate, Ambala Cantt 133006, Haryana.

Expires on or after
October, 2025

liver
Caution should be taken when using Butapar MR Tablet in patients with liver disease. Limited information is available regarding its safety in such cases. It is advised to consult with your doctor before using this medication to ensure proper guidance and monitoring.

kidney
Limited information is available on the use of Butapar MR Tablet in patients with kidney disease. Please consult your doctor.

alcohol
It is not known if it is safe to drink alcohol while taking Butapar MR Tablet. Consult your doctor for guidance.

driving
It is not confirmed if taking Butapar MR Tablet affects driving abilities. If symptoms impair focus and reaction, avoid driving while using this medication.

pregnancy
Information about the safety of Butapar MR Tablet during pregnancy is not known. It is recommended to consult your doctor before using this medicine while pregnant.

breastfeeding
It is better to consult your doctor before using Butapar MR Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹24
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024